SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
US Stock Market Move | NVIDIA Corporation-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, rises over 11% after the open.
US Stock Market Move | 3D printing materials supplier Amaero (AMRO.US) debuts on the U.S. stock market, triggering a circuit breaker after the open.
Amid market concerns over debt default risks, CoreWeave (CRWV.US) receives backing from Jensen Huang: financial strength continues to improve, financing costs are declining.
US Stock Market Move | NVIDIA Corporation-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, rises over 11% after the open.
US Stock Market Move | 3D printing materials supplier Amaero (AMRO.US) debuts on the U.S. stock market, triggering a circuit breaker after the open.
Amid market concerns over debt default risks, CoreWeave (CRWV.US) receives backing from Jensen Huang: financial strength continues to improve, financing costs are declining.
